168 related articles for article (PubMed ID: 28408701)
21. Striated duct adenoma presenting with intra-tumoral hematoma and papillary thyroid carcinoma-like histology.
Ito Y; Fujii K; Murase T; Saida K; Okumura Y; Takino H; Masaki A; Beppu S; Kawakita D; Ijichi K; Inagaki H
Pathol Int; 2017 Jun; 67(6):316-321. PubMed ID: 28440555
[TBL] [Abstract][Full Text] [Related]
22. Conversion of non-iodine-concentrating differentiated thyroid carcinoma metastases into iodine-concentrating foci after anticancer chemotherapy.
Morris JC; Kim CK; Padilla ML; Mechanick JI
Thyroid; 1997 Feb; 7(1):63-6. PubMed ID: 9086573
[TBL] [Abstract][Full Text] [Related]
23. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
24. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
25. Inactive pulmonary tuberculosis mimicking metastasis from papillary thyroid carcinoma in diagnostic radioiodine whole-body scintigraphy.
Picolos MK; Habra M; Safdar A; Sarlis NJ
Thyroid; 2005 Sep; 15(9):1105-6. PubMed ID: 16187924
[No Abstract] [Full Text] [Related]
26. False-positive radioiodine whole-body scan in thyroid cancer patients due to unrelated pathology.
Bakheet SM; Hammami MM
Clin Nucl Med; 1994 Apr; 19(4):325-9. PubMed ID: 8004865
[TBL] [Abstract][Full Text] [Related]
27. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
28. Incidental 131I Activity in the Deltoid Region on Posttherapy Radioiodine Scan.
Strober MD; Callahan BR
Clin Nucl Med; 2017 Nov; 42(11):899-900. PubMed ID: 28902736
[TBL] [Abstract][Full Text] [Related]
29. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
30. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma.
Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R
J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995
[TBL] [Abstract][Full Text] [Related]
31. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
[TBL] [Abstract][Full Text] [Related]
32. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen® (recombinant human thyroid stimulating hormone--thyrotropin alfa).
Gonzalez ME; Muttikkal TJ; Rehm PK
J Radiol Case Rep; 2015 Jun; 9(6):44-9. PubMed ID: 26622936
[TBL] [Abstract][Full Text] [Related]
33. Clinical experience with recombinant human thyrotrophin (rhTSH) in the management of patients with differentiated thyroid cancer.
Mariani G; Ferdeghini M; Augeri C; Villa G; Taddei GZ; Scopinaro G; Boni G; Bodei L; Rabitti C; Molinari E; Bianchi R
Cancer Biother Radiopharm; 2000 Apr; 15(2):211-7. PubMed ID: 10803328
[TBL] [Abstract][Full Text] [Related]
34. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
Schmidt M; Dietlein M; Schröder U; Schicha H
Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
[TBL] [Abstract][Full Text] [Related]
35. Thyroid papillary carcinoma presenting as jaw and parotid gland metastases.
Markitziu A; Fisher D; Marmary Y
Int J Oral Maxillofac Surg; 1986 Oct; 15(5):648-53. PubMed ID: 3097195
[TBL] [Abstract][Full Text] [Related]
36. Isolated porta hepatis metastasis of papillary thyroid cancer.
Bakheet SM; Powe J; Hammami MM; Amin TM; Akhtar M; Ahmed M
J Nucl Med; 1996 Jun; 37(6):993-4. PubMed ID: 8683330
[TBL] [Abstract][Full Text] [Related]
37. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
[TBL] [Abstract][Full Text] [Related]
38. Successful pregnancy without disease progression of radioiodine refractory papillary thyroid carcinoma: a case report.
Jin Y; Liu M; Cheng L; Chen L
BMC Cancer; 2017 Nov; 17(1):735. PubMed ID: 29121867
[TBL] [Abstract][Full Text] [Related]
39. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
Giovanella L; Ceriani L; Ghelfo A; Keller F
Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
[TBL] [Abstract][Full Text] [Related]
40. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
Thientunyakit T
Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
